← Emergent BioSolutions Inc. EBS
Market Price
$4.60
Market Cap
$230.22M
P/E Ratio
4.95
Revenue (FY 2025)
↓-28.8% YoY
$742.90M
3-Yr CAGR: -12.7%
Net Income
↑127.6% YoY
$52.60M
Net Margin: 7.1%
Free Cash Flow
↑338.0% YoY
$156.80M
FCF Yield: 68.11%
EPS (Diluted)
↑125.8% YoY
$0.93
Basic: $0.98
Return on Equity
Efficiency
10.1%
ROA: 203.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (EBS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $488.8M | — | $357.5M | $51.8M | — | $1.13 | — | $53.5M | $-22.8M | — |
| FY 2017 | $560.9M | +14.7% | $365.2M | $82.6M | +59.5% | $1.71 | +51.3% | $208.1M | $153.3M | +773.3% |
| FY 2018 | $782.4M | +39.5% | $460.1M | $62.7M | -24.1% | $1.22 | -28.7% | $41.8M | $-30.3M | -119.8% |
| FY 2019 | $1,106.0M | +41.4% | $672.5M | $54.5M | -13.1% | $1.04 | -14.8% | $188.0M | $101.1M | +433.7% |
| FY 2020 | $1,555.4M | +40.6% | $1,031.4M | $305.1M | +459.8% | $5.67 | +445.2% | $536.0M | $395.0M | +290.7% |
| FY 2021 | $1,792.7M | +15.3% | $701.0M | $230.9M | -24.3% | $4.27 | -24.7% | $321.1M | $96.1M | -75.7% |
| FY 2022 | $1,117.5M | -37.7% | $383.0M | $-211.6M | -191.6% | $-4.22 | -198.8% | $-34.1M | $-149.9M | -256.0% |
| FY 2023 | $1,049.3M | -6.1% | $317.6M | $-760.5M | -259.4% | $-14.85 | -251.9% | $-206.3M | $-257.9M | -72.0% |
| FY 2024 | $1,043.6M | -0.5% | $199.3M | $-190.6M | +74.9% | $-3.60 | +75.8% | $58.7M | $35.8M | +113.9% |
| FY 2025 | $742.9M | -28.8% | $416.7M | $52.6M | +127.6% | $0.93 | +125.8% | $170.6M | $156.8M | +338.0% |
Valuation
Market Price
$4.60
Market Cap
$230.22M
Enterprise Value
$596.92M
P/E Ratio
4.95
P/B Ratio
0.45
FCF Yield
68.11%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
56.09%
Operating Margin
13.47%
Net Margin
7.08%
Return on Equity (ROE)
10.07%
Return on Assets (ROA)
203.88%
Asset Turnover
28.79x
Revenue 3-Yr CAGR
-12.72%
Financial Health & Liquidity
Current Ratio
2.11
Cash Ratio
16.84
Debt / Equity
1.095
Debt / Assets
22.174
Cash & Equivalents
$205.40M
Total Debt
$572.10M
Book Value / Share
$10.19
Cash Flow Efficiency
Operating Cash Flow
$170.60M
Capital Expenditures (CapEx)
$13.80M
Free Cash Flow
$156.80M
OCF / Revenue
22.96%
FCF / Revenue
21.11%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.93
EPS (Basic)
$0.98
Dividends / Share
N/A
Book Value / Share
$10.19
EPS YoY Growth
125.83%
Balance Sheet (FY 2025)
Total Assets
$25.80M
Total Liabilities
$12.20M
Stockholders' Equity
$522.60M
Current Assets
$25.80M
Current Liabilities
$12.20M